Skip to main content
Turkish Journal of Urology logoLink to Turkish Journal of Urology
. 2013 Dec;39(4):281–284. doi: 10.5152/tud.2013.068

Inflammatory pseudotumor of the epididymis: a case report and review of the literature

Recep Bedir 1,, İbrahim Şehitoğlu 1, Hakkı Uzun 2, Cüneyt Yurdakul 1
PMCID: PMC4548605  PMID: 26328125

Abstract

Inflammatory pseudotumors (IPTs) are rare benign tumor-like lesions in the epididymis. They result from myofibrohistiocytic proliferation of the parenchymal organs of the body, such as the lungs and genitourinary system. A 48-year-old male patient presented with a palpable left scrotal mass and developed painless swelling within two months. Scrotal ultrasound revealed a 3 cm solid mass and spermatocele sac in the epididymis. Local excision was performed. Histopathologic and immunohistochemical examination revealed an inflammatory pseudotumor. Only ten cases have been reported in the literature to date. We present our case of pseudotumor of the epididymis as the eleventh case reported in the literature with a brief review.

Keywords: Epididymis, inflammatory pseudotumor, spermatocele

Introduction

Inflammatory pseudotumor (IPM) is a benign tumor-like lesion seen in various organs of our body most frequently encountered in the lungs. Macroscopically it is a non-capsulated lesion with well-defined contours, nodular, and diffuse growth patterns. Microscopically, spindle cell proliferation in loose collagenized stroma intermingled with infiltration of mixed type inflammatory cell. Previously various nomenculatures have been proposed for this lesion including fibroma, pseudofibromatous periorchitis, reactive periorchitis, inflammatory myofibroblastic tumor, atypical myofibroblastic tumor, plasma cell granuloma, pseudosarcomatous myofibroblastic proliferation, pseudosarcoma, and fibrous pseudotumor.[1,2] Paratesticular IPT constitutes 6% of paratesticular lesions, and tumors. Epididymal IPT is a rarely seen lesion, up to now only 10 cases have been cited in the literature.[24]

Herein we aimed to discuss clinical, and histopathological features of a rare case of epididymal IPT seen in a 48-year-old patient in the light of the literature.

Case presentation

A 48-year-old male patient consulted to out-patient urology clinic with left scrotal painless swelling. It was learnt that this swelling was present for 2 months, and grew in size with time. Dysuria, urinary tract infection, and hematuria were not observed. History of trauma, and radiotherapy were not revealed. On physical examination a solid left scrotal mass measuring nearly 3×2×1.5 cm was detected. On scrotal ultrasonogram, a solid mass at the tip of the left epididymis in the paratesticular region was observed. Besides, a pale yellow colored fluid draining from a spermatocele sac with a diameter of 10 cm was noted. Organ-preserving surgery was applied, and only mass lesion, and spermatocele sac were excised. A solid mass lesion with a diameter of 3 cm, and smooth contours having a grayish-white cross-sectional area was observed. On microscopic examination, chronic inflammatory cell infiltration rich in plasma cells within a collagenous stroma with decussated spindle cells, and proliferation of vascular structures were observed (Figure 1). Immunohsitochemical examination revealed vimentine positivity in collagen bundles, and smooth muscle actin (SMA) positivity within myofibroblastic cells. (Figures 2, 3). Signs of mitosis, necrosis, and anaplasia were not observed. As a result of all these findings, the diagnosis of inflammatory pseudomotor was made. On spermatocele sac, a cystic structure with a fibrous thin membrane lined with a single row of depressed cubic epithelium was observed (Figure 4). Written informed consent form was obtained from the patient.

Figure 1.

Figure 1.

Spindle-like myofibroblastic cells (large arrow), chronic inflammatory cell infiltration (thin arrow), and vascular proliferation in loose collagenous stroma (H&E × 200)

Figure 2.

Figure 2.

SMA positive areas (arrow) in myofibroblastic spindle cells (× 200)

Figure 3.

Figure 3.

Vimentine positive areas (arrow) between intermingled collagen fibrils

Figure 4.

Figure 4.

Spermatocel sac with a thin fibrous wall (large arrow) lined with single layer of depressed cubic epithelium (thin arrow) (H&E × 200)

Discussion

Epididymal IPT was firstly defined by Lam et al.[5] Mostly, they are detected incidentally without history of any previous disease. Although, its etiology is not known fully, it is thought to arise from a reactive response emerging as a result of chronic irritation, infection, trauma, and ischemia. Although Ebstein-Barr virus, Mycobacterium avium-intracellulare, and Human Herpes virus-8 have been suggested to play a role in the etiology of IPT, this association has not been hitherto definitively confirmed.[2,6,7] Chan et al.[8] tested small nuclear RNA 1, and 2 of EBV in reported cases of IPT in lymph nodes, liver, and spleen using in-situ hybridization method. However they couldn’t observe EBV RNA in 2 cases with epididymal IPT which might suggest a different etiology stemming from reticuloendothelial system organs.

Cases with inflammatory psudotumor usually manifest themselves as a scrotal mass. On scrotal ultrasonograms, the nature of the mass lesion, and its relationship with surrounding structures are analyzed. Scrotal ultrasonographic image of paratesticular IPT has been firstly described by Kapur et al.[9] as a lobular hypervascular mass with heterogenous echogenicity. Later on, Megremis et al.[10] defined scrotal ultrasonographic image of a second case of paratesticular mass as a septated, cystic-solid hypoechoic mass impinging on surrounding testicular tissue. Macroscopically, they are mostly solid, nodular lesions with well-defined contours, and a grayish white cross-sectional area occasionally demonstrating cystic, and hemorrhagic areas. Microscopic examination reveals spindle cell proliferation which can demonstrate myofibroblastic differentiation in loose collagenous tissue, mixed inflammatory cell infiltration, and hypervascularity just as seen in granulation tissue.Inflammatory cells rich in plasmocytes which may be associated with lymphocytes, neutrophil leukocytes, eosinophil leukocytes, and histiocytes are observed. Occasionally, hyalinization, and calcification can be detected in the tumor.[2,6,7,11] Though IPT is a benign tumor, it can often clinically mimick intrascrotal malignancies. For this reason, definitive preoperative diagnosis can not be made. Definitive diagnosis is based on histopathological analysis.[12] Immunohistochemical analysis aids in confirmation of the diagnosis. Vimentine, SMA, and CD68 positivity are observed. Besides anaplastic lymphoma kinase (ALK) contained in myofibroblastic cells retains cytoplasmic dyes. It has been reported that in 50% of the cases, ALK retained cytoplasmic dyes, and especially in young patients it was more strongly expressed.[2,7] Still in our case, vimentine in mesenchymal cells, SMA in smooth muscle cells, and CD68 in histiocytes were positively stained, on the contrary ALK positivity could not be detected. Our findings demonstrate similarities with histochemical, and immunohistochemical findings of some other reported cases in the literature (Table 1).

Table 1.

A brief summary of the information on cases with IPT as reported in the literature

References Age (years) Immuınohistochemical findings Treatment Location Follow-up
Orosz et al.[1] 63 SMA (+), vimentin (+), desmin (−), S-100(−), SMA (+), vimentin (+), desmin (−), S-100 (−) Radical orchidectomy Left scrotal mass
Lam et al.[5] 43 Vimentin (+), SMA (+), desmin (−), cytokeratin (−) Initial antibiotherapy, then limited surgical excision Left scrotal mass Lack of recurrence after 6 months of follow-up
Chan et al.[8] 43 Polyclonal plasma cells (+) for light chain Radical orchidectomy Left scrotal mass
Jha et al.[12] 32 Vimentin (+), SMA (+) Left orchidectomy Left scrotal mass
Brauers et al.[13] 73 Vimentin (+), CD68 (+), SMA (+), desmin (−), myoglobin (−), myosin (−) Epididymectomy Left scrotal mass
Cooperman et al.[3] 30 Excision of the mass Left scrotal mass
Kapur et al.[9] 36 Vimentin (+), SMA (+), sitokeratin (−), desmin (−), CD34 (−) ALK (−), inhibin (−) Radical orchidectomy Left scrotal mass
Megremis et al.[10] 45 SMA (+), desmin (+), CD34 (−) S-100 (−), cytokeratin (−), ALK (−) Radical orchidectomy Left scrotal mass Lack of recurrence after 3 months of follow-up
Dangle et al.[7] 22 Vimentin (+), SMA (+), CD3 (+), CD20 (+), CD68 (+), ALK-1 (−), CD138 (−) Radical orchidectomy Left scrotal mass Lack of recurrence after 4 years of follow-up
Tunuguntla et al.[2] 17 Radical orchidectomy Left scrotal mass
Our case 42 Vimentin (+), SMA (+), CD68 (+), ALK (−) Local excision Left scrotal mass Lack of recurrence after a year of follow-up

In the differential diagnosis of paratesticular IPT, various neoplastic, and inflammatory lesions of the testis, and epididymis should be considered. These lesions include myxoid liposarcoma, rhabdomyosarcoma, sarcomatoid carcinoma, inflammatory fibrosarcoma, and liposarcoma, malignant fibrous histiocytoma, spermatocele, varicocele, and rarely tuberculous involvement.[2] In our case mitosis, pleomorphism, and necrosis were not observed. Non-surgical treatment alternatives for IPT outside genitourinary system include drug therapy (cyclosporines, corticosteroids, methotrexate, antibiotics), and radiotherapy.[7] Treatment of IPT is surgery with many alternatives. Cooperman et al.[3] recommended local excision for extratesticular mass lesions whose discrimination from normal testicular tissue was confirmed by ultrasonographic examination, and its malignancy was excluded by frozen section biopsy. Brauers et al.[13] suggested excision of normal testis, and epididymectomy for a clinically palpable mass measuring 1 cm in diameter. However Lam et al.[5] recommended orchidectomy for solid scrotal mass lesions which can not be clinically discriminated from testis. Following complete surgical excision of the tumor or combined organ-preserving surgery recurrences are rarely seen.[10] Kapur et al.[9] reported that in recurrent cases where surgical treatment failed, radiotherapy, methotrexate, and corticosteroids could be used. In our case since suggestively benign mass was in extratesticular location, and ultrasonograms could discriminate it from the normal testicular tissue, spermatocele was locally excised together with its sac. Abdominal, and retroperitoneal variants of this tumor have a more agressive potential, however for epididymal IPT any incident of recurrence has not been reported up to now.[7] During one year of follow-up period any incident of recurrence was not detected.

In conclusion, since mass lesions localized in testis, and epididymis can not be clinically discriminated easily as benign, and malignant, for definitive diagnosis histopathological examination should be performed following surgical excision. In the differential diagnosis of paratesticular mass lesions, even though rarely seen, IPT should be kept in mind.

Footnotes

Informed Consent: Written informed consent was obtained from patient who participated in this case.

Peer-review: Externally peer-reviewed.

Author Contributions: Concept - R.B.; Design - R.B., İ.Ş.; Supervision - R.B., C.Y.; Funding - R.B.; Data Collection and/or Processing - R.B., C.Y.; Analysis and/or Interpretation - R.B.; Literature Review - R.B.; Writer - R.B.; Critical Review - R.B.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study has received no financial support.

References

  • 1.Orosz Z, Besznyák I. Diffuse Inflammatory Pseudotumor of the Testis, the Epididymis and the Spermatic Cord. Pathol Oncol Res. 1995;1:75–9. doi: 10.1007/BF02893588. [DOI] [PubMed] [Google Scholar]
  • 2.Tunuguntla H, Mishra A, Jorda M, Gosalbez R. Inflammatory myofibroblastic tumor of the epididymis: case report and review of the literature. Urology. 2011;78:183–5. doi: 10.1016/j.urology.2010.09.027. [DOI] [PubMed] [Google Scholar]
  • 3.Cooperman R, White B, Zincke JP, Kardon D, Andrawis R. Extratesticular inflammatory myofibroblastic tumor. J Urol. 2003;169:1473. doi: 10.1097/01.ju.0000054925.34848.9c. [DOI] [PubMed] [Google Scholar]
  • 4.Gleason BC, Hornick JL. Inflammatory myofibroblastic tumor: where are we now? J Clin Pathol. 2008;61:428–37. doi: 10.1136/jcp.2007.049387. [DOI] [PubMed] [Google Scholar]
  • 5.Lam KY, Chan KW, Ho MHM. Inflammatory pseudotumor of the epididymis. Br J Urol. 1995;75:255–7. doi: 10.1111/j.1464-410x.1995.tb07330.x. [DOI] [PubMed] [Google Scholar]
  • 6.Karahan N, Çandır Ö. Inflammatory epididymal pseudotumor. A case report. Genel Tıp Derg. 2006;16:125–8. [Google Scholar]
  • 7.Dangle PP, Wang WP, Pohar KS. Inflammatory myofibroblastic tumor of epididymis: a case report and review of literature. World J Surg Oncol. 2008;6:119. doi: 10.1186/1477-7819-6-119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chan KW, Chan KL, Lam KY. Inflammatory pseudotumor of epididymis and Ebstein-Barr virüs: a study of two cases. Pathology. 1997;29:100–1. doi: 10.1080/00313029700169664. [DOI] [PubMed] [Google Scholar]
  • 9.Kapur P, Treat T, Chuang AT, Hoang M. Pathologic quiz case: paratesticular mass in young man. Inflammatory myofibroblastic tumor of the paratestis. Arc Pathol Lab Med. 2004;128:589–90. doi: 10.5858/2004-128-589-PQCPMI. [DOI] [PubMed] [Google Scholar]
  • 10.Megremis S, Papamitsaki E, leromonachou P, Zois E. Inflammatory myofibroblastic tumor of the paratestis sonographic appearance with pathologic correlation. J Ultrasound Med. 2007;26:1227–30. doi: 10.7863/jum.2007.26.9.1227. [DOI] [PubMed] [Google Scholar]
  • 11.Oliva E. Young RH. Paratesticular tumor-like lesions. Semin Diagn Pathol. 2000;17:340–58. [PubMed] [Google Scholar]
  • 12.Jha A, Baidya JL, Batajoo R. Paratesticular fibrous pseudotumor arising from tunica vaginalis. Nepal Med Coll J. 2009;11:145–6. [PubMed] [Google Scholar]
  • 13.Brauers A, Striepecke E, Mersdof A, Sohn M, Fiuzesi L. Inflammatory pseudotumor of the epididymis. Eur Urol. 1997;32:253–5. [PubMed] [Google Scholar]

Articles from Turkish journal of urology are provided here courtesy of Turkish Association of Urology

RESOURCES